Dr. Gebrael is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
30 N Mario Capecchi Dr
Helix 3RD floor North
Salt Lake City, UT 84112Phone+1 801-581-7606
Education & Training
- Saint Joseph University of BeirutClass of 2022
Awards, Honors, & Recognition
- Conquer Cancer Merit Award American Society of Clinical Oncology 2024
- Conquer Cancer Merit Award American Society of Clinical Oncology, 2023
Publications & Presentations
PubMed
- Real-world Effectiveness of Single-Agent Enfortumab Vedotin in Patients With Advanced Urothelial Carcinoma.Nicolas Sayegh, Yeonjung Jo, Georges Gebrael, Nishita Tripathi, Beverly Chigarira
Clinical Genitourinary Cancer. 2025-02-01 - Genomic biomarkers of survival in patients with metastatic hormone-sensitive prostate cancer undergoing intensified androgen deprivation therapy.Georges Gebrael, Nicolas Sayegh, Chadi Hage Chehade, Yeonjung Jo, Arshit Narang
Prostate Cancer and Prostatic Diseases. 2025-01-31 - A pan-tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors.Chadi Hage Chehade, Georges Gebrael, Nicolas Sayegh, Zeynep Irem Ozay, Arshit Narang
CA. 2025-01-10
Press Mentions
- Baseline Bone Pain Associated with Worse Survival in Metastatic Prostate CancerApril 4th, 2024
Other Languages
- Arabic, French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: